NCT01355393 2020-02-10
Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer
University of Washington
Phase 1/2 Completed
University of Washington
National Institutes of Health Clinical Center (CC)
University of Washington
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)